Medicus Wins $50 Mil.-Plus Nolvadex Task

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Medicus Communications has been awarded integrated marketing duties for Zeneca’s Nolvadex brand, following a review. Pending regulatory approval, the client is hoping to spend in excess of $50 million on advertising in the coming year, sources said.
Nolvadex, the brand name of the hormonal therapy tamoxifen citrate, is now prescribed after a patient has been treated for breast cancer to prevent a return of the disease. An independent study published in April by the National Cancer Institute indicated the drug may prevent breast cancer in healthy women with a high risk of developing the disease.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in